Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Martin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|March 4, 2015
[Calciphylaxis]Vincent M Brandenburg, Heike Martin, Christoph Müller Philipps Sohn, et al.
Family Practice|April 18, 2008
Simply no time? Barriers to GPs' participation in primary health care researchEva Hummers-Pradier, Christa Scheidt-Nave, Heike Martin, et al.
Advances in Therapy|November 5, 2014
Preservation of anemia control and weekly ESA dosage after conversion from PEG-Epoetin beta to darbepoetin alfa in adult hemodialysis patients: the TRANSFORM studyJan Donck, Lourdes Gonzalez-Tabares, Jacques Chanliau, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 18, 2021
Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and haemodialysis patients using messenger RNA vaccinesJulian Stumpf, Anna Klimova, René Mauer, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 25, 2019
Patient Perspectives on Renal Replacement Therapy Modality Choice: A Multicenter Questionnaire Study on Bioethical DimensionsMichael S Balzer, Christian Clajus, Gabriele Eden, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|August 19, 2021
Barriers and opportunities to increase PD incidence and prevalence: Lessons from a European SurveyUlrika Hahn Lundström, Alferso C Abrahams, Jennifer Allen, et al.
Vaccines|July 27, 2024
Hybrid Immunity Protects against Antibody Fading after SARS-CoV-2mRNA Vaccination in Kidney Transplant Recipients, Dialysis Patients, and Medical Personnel: 9 Months Data from the Prospective, Observational Dia-Vacc StudyJulian Stumpf, Torsten Siepmann, Jörg Schwöbel, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 21, 2021
Assisted peritoneal dialysis across Europe: Practice variation and factors associated with availabilityAnita van Eck van der Sluijs, Brigit C van Jaarsveld, Jennifer Allen, et al.
Vaccine|December 19, 2023
9-Month observational Dia-Vacc study of vaccine type influence on SARS-CoV-2 immunity in dialysis and kidney transplant patientsJulian Stumpf, Leona Anders, Torsten Siepmann, et al.
The Lancet Regional Health. Europe|April 18, 2022
Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc studyJulian Stumpf, Jörg Schwöbel, Tom Lindner, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|March 4, 2015
[Calciphylaxis]Vincent M Brandenburg, Heike Martin, Christoph Müller Philipps Sohn, et al.
Family Practice|April 18, 2008
Simply no time? Barriers to GPs' participation in primary health care researchEva Hummers-Pradier, Christa Scheidt-Nave, Heike Martin, et al.
Advances in Therapy|November 5, 2014
Preservation of anemia control and weekly ESA dosage after conversion from PEG-Epoetin beta to darbepoetin alfa in adult hemodialysis patients: the TRANSFORM studyJan Donck, Lourdes Gonzalez-Tabares, Jacques Chanliau, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 18, 2021
Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and haemodialysis patients using messenger RNA vaccinesJulian Stumpf, Anna Klimova, René Mauer, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 25, 2019
Patient Perspectives on Renal Replacement Therapy Modality Choice: A Multicenter Questionnaire Study on Bioethical DimensionsMichael S Balzer, Christian Clajus, Gabriele Eden, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|August 19, 2021
Barriers and opportunities to increase PD incidence and prevalence: Lessons from a European SurveyUlrika Hahn Lundström, Alferso C Abrahams, Jennifer Allen, et al.
Vaccines|July 27, 2024
Hybrid Immunity Protects against Antibody Fading after SARS-CoV-2mRNA Vaccination in Kidney Transplant Recipients, Dialysis Patients, and Medical Personnel: 9 Months Data from the Prospective, Observational Dia-Vacc StudyJulian Stumpf, Torsten Siepmann, Jörg Schwöbel, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|October 21, 2021
Assisted peritoneal dialysis across Europe: Practice variation and factors associated with availabilityAnita van Eck van der Sluijs, Brigit C van Jaarsveld, Jennifer Allen, et al.
Vaccine|December 19, 2023
9-Month observational Dia-Vacc study of vaccine type influence on SARS-CoV-2 immunity in dialysis and kidney transplant patientsJulian Stumpf, Leona Anders, Torsten Siepmann, et al.
The Lancet Regional Health. Europe|April 18, 2022
Risk of strong antibody decline in dialysis and transplant patients after SARS-CoV-2mRNA vaccination: Six months data from the observational Dia-Vacc studyJulian Stumpf, Jörg Schwöbel, Tom Lindner, et al.
Pageof 2